FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/21/2026
Back to search
Official data from USPTO
REXULTI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
07/21/2026
Trademark type
Word
Nice classes
10
Filing date
02/27/2025
Registration date
04/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Otsuka Pharmaceutical Co., Ltd.
Representatives
Scott S. Havlick Holland & Hart LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseasesdementiaAlzheimer's disorder and diseasedizzinessseizuresstrokedepressioncognitive impairmentcognitive disorders and diseasesmood disorderspsychosisanxietyapathyepilepsyLennox-Gastaut syndrome (LGS)sclerosisporphyriaHuntington's disorder and diseaseinsomniaParkinson's disorder and diseasefallsmovement disorders and diseasestremorschizophreniabipolar disorder and diseasemaniaADHDPTSDagitationaggressionautismmelancholyOCDTourette's syndromeprogressive supranuclear palsy (PSP)restlessnessakathisiafatiguesomnolencenauseacancermigrainepainalcoholism and dependency; injection devices for pharmaceuticalssold emptyfor medical purposes; syringes and needles for injections and medical purposes; apparatus and instruments for diagnostic purposesintegrated medical systems comprising medical diagnostic imaging apparatus and downloadable software sold as a unit therewith for managingmeasuringmonitoringassessingcontrollingcollectingstoringexamining patient and client data and information captured by the medical system in web-based physicalpsychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosagemeasuring and monitoringdrug delivery devices and systems in the nature of medical syringes
Publications
History of USPTO decisions and trademark events.
24 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/21/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2026
PUBO
PUBLISHED FOR OPPOSITION
03/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/25/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/19/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/30/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/29/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/29/2026
RFNT
REFUSAL PROCESSED BY IB
10/24/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/26/2025
RFRR
REFUSAL PROCESSED BY MPU
09/25/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/15/2025
CNRT
NON-FINAL ACTION WRITTEN
08/14/2025
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
08/13/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/02/2025
CNRT
NON-FINAL ACTION WRITTEN
07/01/2025
DOCK
ASSIGNED TO EXAMINER
06/18/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/09/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/09/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/08/2025
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
04/03/2025
Continuous trademark protection
Get notified about every new filing that threatens REXULTI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.